When Recursion Pharmaceuticals and Exscientia announced plans to merge in August, it marked the first major consolidation in the early AI-driven biotech field.
The all-stock deal, touted as an alliance between biology and chemistry, caught many in the industry by…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Members of Utah’s medical licensing board have called for the suspension of a temporary program allowing a startup to use AI to refill prescription medications. The startup, Doctronic, struck an agreement with Utah’s Office of […]
Progress on more than a dozen powerful new generative AI capabilities across the revenue cycle Pilot program already shows promising results of enhancing productivity by 5X and accuracy by more than 10% LEHI, Utah and […]
TEL AVIV, Israel and LEHI, Utah–(BUSINESS WIRE)– #dna–MyHeritage, the leading global platform for family history and DNA testing, has expanded its reach by making its website fully available in 50 languages. This expansion marks another […]
Copyright © 2026 Biotech Networks
